While Apple and Samsung are known to have the best smartwatches in the market, Garmin has amped up its offerings by adding advanced health features to its Venu 2 Plus smartwatches, like allowing users to take an electrocardiogram reading within seconds. Introduced at CES 2022, the smartwatch will now feature in-depth capabilities at an affordable price.
By integrating FDA-approved ECG into its Venu 2 Plus smartwatch, the company lets users record a 30-second electrocardiogram to screen for abnormal heart rhythms. It is an indicator of atrial fibrillation. The results will be able on the screen and users can even share them with doctors for further medical treatments. For now, this feature is only available to users based in the USA.
“The ECG App is Garmin’s first FDA-cleared smartwatch feature and we are thrilled to offer this revolutionary tool to our customers as another way to stay on top of their health,” said Dan Bartel, Garmin vice president of global consumer sales. “During the early stages of AFib, it’s common for symptoms to be infrequent, making it difficult to detect in a clinical setting. With the new ECG App, Venu 2 Plus customers can conveniently take an ECG recording anytime and optionally create a report of their results to share with their doctor later.”
While this feature isn’t revolutionary and can be easily found in other smartwatches, it is a pushback from Garmin to its competitors. Over the last few years, the company has added various advanced health and training features to its rugged fitness watches. It has helped the company stand out and become a convenient smartwatch alternative to Fitbit.
